Warren Buffett's company reported less than half as much profit in the second quarter as it took a $3.76 billion writedown on ...

For the third quarter, the stent maker forecast earnings in a range between 44 cents and 46 cents a share on sales growth of about 17%-to-19%. On an adjusted basis, Boston Sci targeted earnings ...

UnitedHealth missed Wall Street’s second-quarter earnings expectations and offered a new and conservative take on the rest of ...

Boston Scientific Corp. closed 2.51% below its 52-week high of $108.94, which the company reached on July 23rd.

Revenue rose 22.8 % to $5.06 billion, beating expectations and guidance.- Adjusted EPS reached $0.75, surpassing analyst ...

Boston Scientific stock broke out Wednesday, helped by a strong second-quarter report on the back of its high-profile ...

In the midst of an artificial intelligence spending spree, Meta posted stronger-than-expected results for the second quarter, ...

General Motors’ profit and revenue declined in its second-quarter but the automaker easily topped expectations and the ...

The company announced a strong quarter and the stock continues to move upwards rebounding from a 52-week low of $49 a share and is trading on Wednesday morning at $77.57. The stock has increased 58% ...

A significant insider transaction involving the exercise of company stock options was reported on July 15, by James J McGonigle, Board Member at FactSet Research Systems ...

Key Points Revenue climbed to $5.06 billion in Q2 2025, up 23% from the prior year period and 3.4% above analyst expectations. Adjusted EPS reached $0.75 for Q2 2025, exceeding estimates for the ...